NO20081082L - Nye piperidinderivater som kjemokinreseptorformulatorer som er nyttige for behandling av respiratoriske sykdommer - Google Patents

Nye piperidinderivater som kjemokinreseptorformulatorer som er nyttige for behandling av respiratoriske sykdommer

Info

Publication number
NO20081082L
NO20081082L NO20081082A NO20081082A NO20081082L NO 20081082 L NO20081082 L NO 20081082L NO 20081082 A NO20081082 A NO 20081082A NO 20081082 A NO20081082 A NO 20081082A NO 20081082 L NO20081082 L NO 20081082L
Authority
NO
Norway
Prior art keywords
formulators
useful
treatment
chemokine receptor
respiratory diseases
Prior art date
Application number
NO20081082A
Other languages
English (en)
Inventor
Marguerite Mensonides-Harsema
Julien Giovannini
Bo-Goran Josefsson
Hakan Schulz
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of NO20081082L publication Critical patent/NO20081082L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/56—Nitrogen atoms
    • C07D211/58—Nitrogen atoms attached in position 4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4468—Non condensed piperidines, e.g. piperocaine having a nitrogen directly attached in position 4, e.g. clebopride, fentanyl
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)

Abstract

hvor m, R1, R2 og R3 er som definert i beskrivelse og krav, salter og polymorfe former derav, fremgangsmåter for fremstilling av forbindelsene, saltene og polymorfene, farmasøytiske preparater som inneholder disse forbindelsene, saltene og/eller de polymorfe formene og deres anvendelse i terapi.
NO20081082A 2005-08-01 2008-02-29 Nye piperidinderivater som kjemokinreseptorformulatorer som er nyttige for behandling av respiratoriske sykdommer NO20081082L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE0501757 2005-08-01
PCT/SE2006/000918 WO2007015664A1 (en) 2005-08-01 2006-07-31 Novel piperidine derivatives as chemokine receptor modulators useful for the treatment of respiratory diseases.

Publications (1)

Publication Number Publication Date
NO20081082L true NO20081082L (no) 2008-02-29

Family

ID=37708909

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20081082A NO20081082L (no) 2005-08-01 2008-02-29 Nye piperidinderivater som kjemokinreseptorformulatorer som er nyttige for behandling av respiratoriske sykdommer

Country Status (12)

Country Link
US (1) US20080194632A1 (no)
EP (1) EP1912942A1 (no)
JP (1) JP2009503063A (no)
KR (1) KR20080032135A (no)
CN (1) CN101233107A (no)
AU (1) AU2006276342A1 (no)
BR (1) BRPI0613925A2 (no)
CA (1) CA2617127A1 (no)
IL (1) IL188856A0 (no)
MX (1) MX2008001067A (no)
NO (1) NO20081082L (no)
WO (1) WO2007015664A1 (no)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR028948A1 (es) * 2000-06-20 2003-05-28 Astrazeneca Ab Compuestos novedosos
TW200738634A (en) * 2005-08-02 2007-10-16 Astrazeneca Ab New salt
TW200825084A (en) 2006-11-14 2008-06-16 Astrazeneca Ab New compounds 521
WO2008100202A1 (en) * 2007-02-14 2008-08-21 Astrazeneca Ab A 2-f luorobenzoate salt and a 2, 6-dif luorobenzoate salt of n-{5-chloro-2- [ ( (2s) -3-{ [1- (4-chlorobenzyl)piperidin-4- yl ] amino } - 2 - hydroxy- 2 -me t hylpr opyl ) oxy] - 4 - hydroxyphenyl } acetamide
US20110136843A1 (en) * 2007-02-23 2011-06-09 Tomas Eriksson Novel Combination of Compounds to be Used in the Treatment of Airway Diseases, Especially Chronic Obstructive Pulmonary Disease (COPD) and Asthma
GB0808709D0 (en) * 2008-05-13 2008-06-18 Astrazeneca Ab New combination 295
BRPI0822693A2 (pt) 2008-05-13 2015-07-07 Astrazeneca Ab Derivados de quinuclidina como antagonistas do receptor muscarínico m3
GB0814729D0 (en) * 2008-08-12 2008-09-17 Argenta Discovery Ltd New combination
US20230167109A1 (en) * 2020-04-24 2023-06-01 Emory University Aminopiperidine Amides, Derivatives, Compositions, and Uses Related to CXCR4 Modulation

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CO5300399A1 (es) * 2000-02-25 2003-07-31 Astrazeneca Ab Heterocicliocs que contienen nitrogeno, proceso para su preparacion y composiciones farmaceuticas que los contienen
AR028948A1 (es) * 2000-06-20 2003-05-28 Astrazeneca Ab Compuestos novedosos
GB0107228D0 (en) * 2001-03-22 2001-05-16 Astrazeneca Ab Chemical compounds
GB0108046D0 (en) * 2001-03-30 2001-05-23 Astrazeneca Ab Chemical compounds
GB0127547D0 (en) * 2001-11-16 2002-01-09 Astrazeneca Ab Chemical compounds
SE0104251D0 (sv) * 2001-12-14 2001-12-14 Astrazeneca Ab Novel compounds
SE0200919D0 (sv) * 2002-03-25 2002-03-25 Astrazeneca Ab Chemical compounds

Also Published As

Publication number Publication date
AU2006276342A1 (en) 2007-02-08
JP2009503063A (ja) 2009-01-29
US20080194632A1 (en) 2008-08-14
WO2007015664A1 (en) 2007-02-08
CA2617127A1 (en) 2007-02-08
BRPI0613925A2 (pt) 2011-02-15
KR20080032135A (ko) 2008-04-14
EP1912942A1 (en) 2008-04-23
CN101233107A (zh) 2008-07-30
IL188856A0 (en) 2008-04-13
MX2008001067A (es) 2008-03-19

Similar Documents

Publication Publication Date Title
NO20081082L (no) Nye piperidinderivater som kjemokinreseptorformulatorer som er nyttige for behandling av respiratoriske sykdommer
NO20091893L (no) Nye 1,4-benzotiepin-1,1-dioksidderivater som er substituert med benzylgrupper, fremgangsmater for fremstilling av medisiner inneholdende forbindelsene og anvendelse derav.
NO20080675L (no) P38-Map kinaseinhibitorer og metoder for deres anvendelse
NO20055977L (no) Nye benzimidazolderivater
NO20063468L (no) Triazolforbindelser og deres anvendelse som metabotrofe glutamatreseptorantagonister
NO20085066L (no) 4,5-difenyl-pyrimidinyl-aminosubstituerte karboksylsyrer, fremgangsmate for deres fremstilling og anvendelse derav som medikamenter
NO20063470L (no) Tetrazolforbindelser og deres anvendelse av metabotrofe glutamatreseptorantagonister
NO20092723L (no) Indazolylester og amidderivater for behandling av gluccocorticoid reseptormedierte sykdommer
NO20075623L (no) Benzodioksan- og benzodioksolanderivater og deres anvendelse
NO20063748L (no) Kinolinderivater og anvendelse derav som mykobakterielle inhibitorer
NO20055219L (no) Nye forbindelser
NO20071137L (no) Nye piperidinderivater for behandling av depresjon
NO20081315L (no) Benzokinazolinderivater og deres anvendelse ved behandling av benlidelser
NO20083427L (no) Cystoksiske midler omfattende nye tomaymycinderivater og deres terapeutiske anvendelse
NO20082065L (no) Nye imidazo[4,5-b]pyridinderivater som inhibitorer av glykogensyntasekinase 3 for anvendelse ved behandling av demens og neurodegenerative forstyrrelser
SE0402735D0 (sv) Novel compounds
NO20053748L (no) Pyrrolopyridazinderivater.
NO20063620L (no) Arylanilinderivater som beta2 adrenergiske receptoragonister
NO20064201L (no) Glukopyranosylsubstituerte benzolderivater, medikamenter inneholdende slike forbindelser, deres anvendelse og fremstilling
NO20081844L (no) Terapeutiske forbindelser
NO20080670L (no) Substituerte piperaziner som metabotrofiske glutamatreseptorantagonister
NO20080445L (no) Nye azetidinderivater som neurokininreseptorantagonister for behandling av gastrointestinale sykdommer
NO20076695L (no) Nye MCHR1-antagonister og deres anvendelse for behandling av MCHR1-medierte tilstander og forstyrrelser
NO20072005L (no) Nye heterocykliske amider
NO20082112L (no) 3-Amino-2-arylpropylazaindoler og deres anvendelse

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application